Nova Iguaçu

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV2 trials
• Hepatitis B1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• ViiV Healthcare2 trials
• GlaxoSmithKline1 trial

Running trials

• Recruiting

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916· Phase 3· ViiV Healthcare· Source

  Contact: Aline Ramalho (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting

Closed trials

• Completed

  Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

  NCT05630820· Phase 3· GlaxoSmithKline· Source

• Completed

  Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

  NCT03016533· Phase 3· ViiV Healthcare· Source